MPO and ischemia reperfusion injury: In addition, Cyclosporine A (CsA) in liposomal formulation (Lipo-CsA) inhibits the inflammation response, including myeloperoxidase (MPO) activity and TNF-α levels, in the model of ischemia reperfusion injury (I/R) cerebral injuries (Partoazar et al., 2017).